Skip to Content
Print Save

618 (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)

Pill with imprint 618 is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 618

Aspirin and Extended-Release Dipyridamole

Imprint
618
Strength
25 mg / 200 mg
Color
Red & White
Size
24.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Platelet aggregation inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0618
Inactive Ingredients
alcohol, ammonia, butyl alcohol, microcrystalline cellulose, D&C Yellow No. 10, FD&C Red No. 40, ferrosoferric oxide, gelatin, hypromellose phthalate (31% phthalate, 40 cst), hypromelloses, isopropyl alcohol, lactose monohydrate, methacrylic acid - methyl methacrylate copolymer (1:2), polyethylene glycol, potassium hydroxide, povidone, propylene glycol, shellac, sodium lauryl sulfate, corn starch, stearic acid, magnesium silicate, tartaric acid, titanium dioxide, triethyl citrate, water

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "618"

Vantin
Propranolol Hydrochloride Extended-Release
Emend

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer